{"title":"The Impact of Laser Energy Levels on In Situ Fenestrations of Aortic Stent Grafts: An On-Bench Study.","authors":"Teodora Ormandzhieva, Florian Elger, Marcello Silvano, Bernd Niemann, Eberhard Grambow","doi":"10.3390/bioengineering13091085","DOIUrl":null,"url":null,"abstract":"<p><p>(1) Background: Laser in situ fenestration (L-ISF) is an endovascular technique used to preserve target vessel patency in urgent or emergency endovascular aortic repair when fenestrated/branched solutions are unavailable or unsuitable, or as a bailout technique for fenestration or branch misalignment. This on-bench study compared different laser energy levels in five commercially available endografts to assess fabric damage and evaluate fenestration quality, dimensions, and recoil. (2) Methods: A total of 102 fenestrations were created using a 2.0 mm excimer laser catheter at low (45 mJ/mm<sup>2</sup>) or high (60 mJ/mm<sup>2</sup>) energy levels and dilated with a 6 mm plain balloon in five polyester endografts (Zenith Alpha, RelayPro, Endurant IIs, Valiant Captivia, Hercules). High-magnification microscopy assessed morphology and fabric damage after puncture, after dilation, and after 24 h. Quantitative measurements included diameters, area, and recoil under standardized study conditions. (3) Results: Valiant exhibited clearer puncture margins and no bulging; Hercules showed frequent tearing and more bulging and warp-aligned recoil at high energy. In Endurant IIs, low-energy L-ISF produced larger diameters and area but also greater recoil. RelayPro revealed stronger surface recoil with high energy. (4) Conclusion: Both low- and high-energy L-ISF were feasible across all tested grafts. A low-energy approach may be preferable for Endurant IIs, potentially reducing the risk of bridging stent graft stenosis.</p>","PeriodicalId":8874,"journal":{"name":"Bioengineering","volume":"13 9","pages":""},"PeriodicalIF":4.4000,"publicationDate":"2026-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13603707/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioengineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3390/bioengineering13091085","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
(1) Background: Laser in situ fenestration (L-ISF) is an endovascular technique used to preserve target vessel patency in urgent or emergency endovascular aortic repair when fenestrated/branched solutions are unavailable or unsuitable, or as a bailout technique for fenestration or branch misalignment. This on-bench study compared different laser energy levels in five commercially available endografts to assess fabric damage and evaluate fenestration quality, dimensions, and recoil. (2) Methods: A total of 102 fenestrations were created using a 2.0 mm excimer laser catheter at low (45 mJ/mm2) or high (60 mJ/mm2) energy levels and dilated with a 6 mm plain balloon in five polyester endografts (Zenith Alpha, RelayPro, Endurant IIs, Valiant Captivia, Hercules). High-magnification microscopy assessed morphology and fabric damage after puncture, after dilation, and after 24 h. Quantitative measurements included diameters, area, and recoil under standardized study conditions. (3) Results: Valiant exhibited clearer puncture margins and no bulging; Hercules showed frequent tearing and more bulging and warp-aligned recoil at high energy. In Endurant IIs, low-energy L-ISF produced larger diameters and area but also greater recoil. RelayPro revealed stronger surface recoil with high energy. (4) Conclusion: Both low- and high-energy L-ISF were feasible across all tested grafts. A low-energy approach may be preferable for Endurant IIs, potentially reducing the risk of bridging stent graft stenosis.
期刊介绍:
Aims
Bioengineering (ISSN 2306-5354) provides an advanced forum for the science and technology of bioengineering. It publishes original research papers, comprehensive reviews, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. All aspects of bioengineering are welcomed from theoretical concepts to education and applications. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, four key features of this Journal:
● We are introducing a new concept in scientific and technical publications “The Translational Case Report in Bioengineering”. It is a descriptive explanatory analysis of a transformative or translational event. Understanding that the goal of bioengineering scholarship is to advance towards a transformative or clinical solution to an identified transformative/clinical need, the translational case report is used to explore causation in order to find underlying principles that may guide other similar transformative/translational undertakings.
● Manuscripts regarding research proposals and research ideas will be particularly welcomed.
● Electronic files and software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material.
● We also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds.
Scope
● Bionics and biological cybernetics: implantology; bio–abio interfaces
● Bioelectronics: wearable electronics; implantable electronics; “more than Moore” electronics; bioelectronics devices
● Bioprocess and biosystems engineering and applications: bioprocess design; biocatalysis; bioseparation and bioreactors; bioinformatics; bioenergy; etc.
● Biomolecular, cellular and tissue engineering and applications: tissue engineering; chromosome engineering; embryo engineering; cellular, molecular and synthetic biology; metabolic engineering; bio-nanotechnology; micro/nano technologies; genetic engineering; transgenic technology
● Biomedical engineering and applications: biomechatronics; biomedical electronics; biomechanics; biomaterials; biomimetics; biomedical diagnostics; biomedical therapy; biomedical devices; sensors and circuits; biomedical imaging and medical information systems; implants and regenerative medicine; neurotechnology; clinical engineering; rehabilitation engineering
● Biochemical engineering and applications: metabolic pathway engineering; modeling and simulation
● Translational bioengineering